Editorial: Ovarian Cancer Targeted Medication: PARP Inhibitors, Anti-Angiogenic Drugs, Immunotherapy, and More, Volume II

Authors

Zhi-Bin Wang
De-Hua Liao
Guang Lei
Zhao-Qian Liu
Nayiyuan Wu
Jing Wang

Language

English

Publication Date

1-1-2025

Journal

Frontiers in Pharmacology

DOI

10.3389/fphar.2025.1552652

PMID

39995412

PMCID

PMC11848066

PubMedCentral® Posted Date

2-10-2025

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Recommended Citation

Wang, Zhi-Bin; Liao, De-Hua; Lei, Guang; et al., "Editorial: Ovarian Cancer Targeted Medication: PARP Inhibitors, Anti-Angiogenic Drugs, Immunotherapy, and More, Volume II" (2025). Faculty, Staff and Student Publications. 6677.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/6677